Ology Bioservices


Ology Bioservices® (Ology Bio) is a US-based biopharmaceutical Contract Development and Manufacturing Organization (CDMO) providing CGMP (and non-GMP) high quality services to our clients for the development and production of cell and gene therapies, viral vectors, oncolytic viruses and vaccines against infectious diseases and cancer. The company has a 183,000 sq. ft, state-of-the-art biopharmaceutical development and manufacturing facility (ISO 9001 certified; BSL-3 capable) in Alachua, Florida with an additional 35,500 sq. ft cell therapy facility in Alameda, CA.  Ology Bio provides services from preclinical through Phase 3 and commercial manufacturing up to the 2,000 L scale. Ology Bio’s cell and gene therapy leaders each have over 20 years of experience and deep knowledge in process development and expansion technologies for gene therapies and adoptive cell therapies, both autologous and allogeneic, with advanced knowledge in iPSCs and CAR-based methodologies. Ology Bio’s clean rooms and production suites are engineered for flexibility around client-specific processes and workflows, both fully CGMP and EU compliant. Ology Bioservices’ unique offerings include its broad experience in adherent and suspension bioreactors for live virus production, Veroplex® Vero cell line for vaccine production, bioanalytical development & testing services and regulatory services supporting IND submission through commercial licensure. To reserve capacity for 2021 productions, visit our website at